674291-05-5

Upstream product

• 57699-53-3 N^α-isobutyl-N^β-Boc-hydrazine 
• 500022-30-0 N'-benzyl-N'-bromoacetyl-hydrazinecarboxylic acid benzyl ester 
• 135942-02-8 N^α-benzyl-N^α-Z hydrazine 
• 357953-50-5 (N'-tert-butoxycarbonyl-N-isobutyl-hydrazino)-acetic acid 

Downstream Products

• 827337-77-9 N'-benzyl-N'-[(N-isobutyl-hydrazino)-acetyl]-hydrazinecarboxylic acid benzyl ester 
• 500022-41-3 N'-(N-benzyl-hydrazinocarbonylmethyl)-N'-isobutyl-hydrazinecarboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Retro hydrazino-azapeptoids as peptidomimetics of proteasome inhibitors

Several groups of proteasome inhibitors are widely used to study the role of the ubiquin proteasome pathway in various cellular processes or as anticancer drugs. Peptidomimetics have been developed to circumvent problems inherent in peptides such as poor

Hydrazino-aza and N-azapeptoids with therapeutic potential as anticancer agents

The ubiquitin-proteasome-mediated degradation pathway plays an important role in regulating protein turnover in eucaryotic cells and, consequently, regulates both cell proliferation and cell death. The proteasome influences many cellular regulatory signal